International Research Journal of Engineering and Technology

January 1, 2017

At present cloud computing is a very famous technology in IT enterprises. For a company, the data stored is extremely very large and it is very adored. Thus, it becomes very important to have the secured use of data. For this most prior option is a private cloud using which we can keep the data more securely than other. In this paper I am going to discuss about how we can access a private cloud and its uses.

Spotlight

Immunocore

Based in Abingdon (UK) and Philadelphia (USA) Immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Its world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells.

OTHER WHITEPAPERS
news image

Validation of ICON™ Automated Cell Counting and Viability Assay

whitePaper | August 10, 2022

Determination of cell viability and concentration using trypan blue exclusion is essential for biotherapeutic workflows, enabling optimisation of protocols, monitoring of changes to the culture environment, and selection of the best clones for culture progression.

Read More
news image

Eliminate Noisy Oxygen Measurements in Bioreactors

whitePaper | March 27, 2023

Controlling the dissolved oxygen level in fermentation vessels and bioreactors is vital to maximizing production yield and ensuring high end-product quality.

Read More
news image

A New Generation of Cancer Immunotherapies

whitePaper | June 9, 2022

Despite recent progress in fighting cancer the sad reality is that it remains a leading cause of morbidity and mortality. Some of the most promising new treatments have emerged from the convergence of the oncology and immunology fields.

Read More
news image

Mainstreaming Cell & Gene Therapies

whitePaper | October 27, 2022

The cell and gene therapy (CGT) market is rapidly transitioning from ultra-niche cutting-edge science to approved and available therapies that can address previously intractable and often devastating diseases.

Read More
news image

Growing a circular economy with fungal biotechnology

whitePaper | August 17, 2022

Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct opportunities for tackling the urgent challenges before all humans.

Read More
news image

Becoming a life sciences superpower

whitePaper | September 1, 2021

This report advocates for increased, long-term public investment in research and innovation, particularly in the life sciences sector, to accelerate the UK on its trajectory as a global leader in the field. This report sets out recommendations ahead of the Comprehensive Spending Review for policymakers to support innovative businesses, achieve the Prime Minister’s aim of becoming a life sciences superpower, and ultimately, deliver health benefits for Britain – and the world – for generations to come.

Read More

Spotlight

Immunocore

Based in Abingdon (UK) and Philadelphia (USA) Immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Its world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells.

Events